IP Experts Discuss US Congressional Changes, Prospects For IP Legislation 13/11/2018 by William New, Intellectual Property Watch 1 Comment NEW YORK – Major changes are coming to the makeup of the US Congress from the perspective of intellectual property policy, and while it may translate into more patent-friendly officials, the prospect for legislation is uneven, a panel of IP experts told a private sector conference here last week.
Key Hepatitis C Drug Licensed To Medicines Patent Pool, Access Expanded For LMICs 12/11/2018 by David Branigan, Intellectual Property Watch 2 Comments A key drug to treat hepatitis C has been licensed to the Medicines Patent Pool, enabling generic production and expanding affordable access to the drug in low and middle-income countries, excluding the very largest. The agreement between the Pool and AbbVie had been over a year in the making, MPP Executive Director Charles Gore told Intellectual Property Watch.
WIPO Members Look At Protection Of Country Names, GIs, Icons 12/11/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment A number of countries are voicing concerns about their country name being used by trademark applicants with no relation to the country, riding on the country’s reputation or geographical relevance. They are also worried about their country name being used as an internet top-level domain name. Those are among the issues being discussed this week at the World Intellectual Property Organization committee on trademarks, along with questions on the protection of geographical indications, and of icons and typeface on the internet.
WTO TRIPS Council Debates Competition Law, Plain Packaging’s Spread To Other Products 12/11/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Trade Organization intellectual property committee met last week with lively discussions on the benefit of IP rights protection for new businesses, and on the role of competition law to prevent abuses of those rights and in particular ensure greater access to medicines. Also, considering the recent WTO Dispute Settlement Body ruling on the tobacco plain packaging, some countries warned against this decision becoming a precedent and spreading to other goods, and undermining trademark protection.
Experts Assess Coming Changes In US Courts And Patentability 09/11/2018 by William New, Intellectual Property Watch 2 Comments NEW YORK — A panel of legal and government experts this week discussed trends in courts in the United States on patent cases and changes underway at the US Patent and Trademark Office. One conclusion? There may be a real shift in what is seen as patentable in the US, but it may take an act of Congress. [Note: part 1 of 2. The second part will address this week’s changes in the US Congress.]
Intangible Capital Rising, IP Key For Start-Ups, Traditional Growth Model Has To Change, Panellists Say 08/11/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The importance of intangible capital is growing and so is the significance of intellectual property, according to some, and in particular in the new economy. Start-ups see intellectual property as an indispensable tool to attract investors and put their innovations onto the market. Developing countries still mainly stuck in what some call the “commodity trap” have to identify and exploit their intellectual property assets, according to panellists at an event held at the World Trade Organization yesterday.
“Peace Has Broken Out” In Software Development, Heralding Open Source As The Future 07/11/2018 by David Branigan, Intellectual Property Watch Leave a Comment “Peace has broken out” between big technology companies and the free and open source software (FOSS) community, according to a leading FOSS advocate, leading a tech industry representative to say, “this is the future.”
USPTO Names Silicon Valley Tech Attorney As New Deputy Director 06/11/2018 by Intellectual Property Watch Leave a Comment The United States Patent and Trademark Office (USPTO) today announced a new deputy director, Laura Peter, a veteran intellectual property attorney, most recently at Silicon Valley cyber-defence firm A10 Networks.
Report Finds “Overpatenting”, Overpricing Of Top Diabetes Drug In US 05/11/2018 by David Branigan, Intellectual Property Watch 1 Comment Non-profit patent researchers studying the most prominent prescription insulin drug to treat diabetes in the United States found it is “overpatented” and “overpriced,” enabling unwarranted price-hikes resulting in rising costs for patients and taxpayers.
USPTO Solicitor/Deputy General Counsel Leaves For DC Law Firm 05/11/2018 by Intellectual Property Watch Leave a Comment Nathan Kelley has stepped down from his role as solicitor and deputy general counsel at the United States Patent and Trademark Office (USPTO) to join the Perkins Coie law firm in Washington, DC. Kelley also had served as chief administrative patent judge in charge of the Patent Trial and Appeal Board (PTAB).